Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 196 participants.
Also called NCT03664414
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 196 participants
- Sponsor
- Maria Eugenia Galván Plata
- Registry
-
NCT03664414
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Mexico
- Registry status
- Unknown status
Technical summary
Registry record NCT03664414. Randomized; double masking; primary purpose treatment. Start 2018-03-01 (actual); primary completion 2019-07-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)
- Acronym
- PENFOSIDINE
- Condition
- Chronic Kidney Disease stage3 and 4
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- pentoxifylline
- Lead sponsor
- Maria Eugenia Galván Plata
- Collaborator
- Centro de Investigación Biomédica de Michoacán.
- Collaborator
- Hospital General Regional N° 1 Instituto Mexicano del Seguro Social.
- Collaborator
- Hospital General de Zona N° 83 Instituto Mexicano del Seguro Social.
- Collaborator
- Coordinación Auxiliar Medica de Investigación en Salud. Delegación Michoacán.
Record details
- Record id
cardio:ct-nct03664414- Content hash
06df214253c7e3ba75bab392c8836b5a1a74feaa2663290a8f90018251e60275